Grants and Contributions:
Title:
Inflammatory Bowel Disease Treatment for Dogs
Agreement Number:
1040007
Agreement Value:
$294,346.00
Agreement Date:
Feb 16, 2026 - Oct 31, 2026
Description:
A project to evaluate early stage development of a therapeutic to treat canines with IBD/CIE.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Charlottetown, Prince Edward Island, CA C1A 1N3
Reference Number:
172-2025-2026-Q4-1040007
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
779424035
Recipient Type:
For-profit organization
Recipient's Legal Name:
Lupvindol Canada Ltd.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
325410